Barclays
ELGX

Barclays’s Endologix Inc ELGX Stock Holding History

Barclays’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2
Closed – – 5867
2020
Q2 		$0 Buy
+2
New +$2 ﹤0.01% 6595
2019
Q4 		– Sell
-117
Closed – – 7198
2019
Q3 		$0 Sell
117
-4,717
-98% -$27.4K ﹤0.01% 7494
2019
Q2 		$35K Buy
4,834
+1,939
+67% +$13.2K ﹤0.01% 6246
2019
Q1 		$19K Buy
+2,895
New +$19.1K ﹤0.01% 6387
2018
Q4 		– Sell
-5,963
Closed -$114K – 7667
2018
Q3 		$114K Buy
5,963
+3,631
+156% +$130K ﹤0.01% 5436
2018
Q2 		$133K Sell
2,332
-1,369
-37% -$69.4K ﹤0.01% 5059
2018
Q1 		$157K Buy
3,701
+524
+16% +$22.5K ﹤0.01% 5042
2017
Q4 		$170K Buy
3,177
+1,143
+56% +$60.4K ﹤0.01% 4826
2017
Q3 		$90K Sell
2,034
-166
-8% -$7.56K ﹤0.01% 4997
2017
Q2 		$107K Sell
2,200
-2,076
-49% -$122K ﹤0.01% 4852
2017
Q1 		$311K Buy
4,276
+1,777
+71% +$118K ﹤0.01% 3878
2016
Q4 		$143K Sell
2,499
-635
-20% -$58.2K ﹤0.01% 4486
2016
Q3 		$400K Buy
3,134
+1,984
+173% +$254K ﹤0.01% 3406
2016
Q2 		$143K Sell
1,150
-949
-45% -$109K ﹤0.01% 4158
2016
Q1 		$168K Buy
2,099
+1,159
+123% +$95.5K ﹤0.01% 3963
2015
Q4 		$85K Sell
940
-275
-23% -$29.5K ﹤0.01% 4510
2015
Q3 		$146K Buy
1,215
+74
+6% +$10K ﹤0.01% 4365
2015
Q2 		$171K Buy
1,141
+949
+494% +$157K ﹤0.01% 4254
2015
Q1 		$33K Sell
192
-1,323
-87% -$200K ﹤0.01% 5572
2014
Q4 		$228K Buy
1,515
+1,437
+1,842% +$179K ﹤0.01% 4536
2014
Q3 		$8K Sell
78
-48
-38% -$6.69K ﹤0.01% 7000
2014
Q2 		$19K Sell
126
-2,725
-96% -$363K ﹤0.01% 6542
2014
Q1 		$342K Buy
2,851
+2,387
+514% +$371K ﹤0.01% 4266
2013
Q4 		$79K Buy
464
+223
+93% +$38.3K ﹤0.01% 5849
2013
Q3 		$39K Sell
241
-84
-26% -$13.2K ﹤0.01% 6197
2013
Q2 		$43K Buy
+325
New +$45.9K ﹤0.01% 6413

Other funds holding ELGX

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Barclays's ELGX Position: Q3 2020 in Review

Barclays sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 2 shares.

Barclays first reported a position in ELGX in Q2 2013 and held it in 26 quarters. The position peaked at $400K in Q3 2016. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

  • Barclays reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
  • Barclays sold 2 Endologix Inc shares in Q3 2020.
  • Barclays first reported a position in Endologix Inc in Q2 2013 and held it in 26 quarters.
  • Barclays's Endologix Inc position peaked at $400K in Q3 2016.
  • 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.